Researchers solve puzzle of recurring viral infection

Afp
Friday 02 April 2010 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

US researchers have uncovered the key to how a prolific virus is able to reinfect individuals despite a strong immune response, possibly opening the way for vaccines to deadly pathogens including HIV and malaria.

In a study of monkeys, scientists at Oregon Health Sciences University found that the common cytomegalovirus (CMV), which has infected up to 80 percent of the adult population, can overcome the body's ability to clean out infected cells unlike most viruses.

"In essence, CMV is able to cutoff an infected cell's call for elimination. This allows CMV to overcome this critical immune barrier during re-infection," explained Klaus Frueh, a senior scientist at the university.

CMV infection is not very serious in adults, but can be deadly in infants, transplant patients and others with suppressed immune systems.

The ability of CMV to bypass the body's immune response makes it difficult to make a vaccine against it, but this study shows how the virus might be useful as a viral vaccine vector, which would carry genetic material from other pathogens into the body.

Most viral vaccine vectors can be used only once, but the ability of CMV to reinfect could make it useful as a vector for vaccines to a number of diseases, including HIV, hepatitis C, malaria parasites and tuberculosis bacteria.

js/mac/rl

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in